Alibaba gives away a CT reader that beat 23 of 26 radiologists

Damo Academy put a Science-validated generalist that reads abdominal CT at 0.913 AUC on Hugging Face, days after it beat 23 of 26 radiologists. The weights are free; the license is non-commercial, and that split decides who actually gets squeezed.

In this storyBABA
Vincent JiangVincent Jiang · 2 min read
Share
A CT scanner control room with two Philips Brilliance monitors, one showing a scout scan of a patient's head and torso, while a technician works at the console.
1 / 6Slide 1 of 6
A CT scanner console during a scan. Alibaba's Damo Academy released RADAR, an open-weights model that reads contrast-enhanced abdominal CT across 18 organs.

A radiologist you can download

The work hospitals pay for, reading an abdominal CT, has a new public benchmark. Alibaba's Damo Academy released RADAR on 18 September, a vision-language model that reads contrast-enhanced abdominal CT across 18 organs and flags 146 clinical findings, including malignant tumors 12. In a reader study spanning multiple hospitals, its average accuracy exceeded that of 23 of 26 radiologists 17. Working with RADAR as a second reader, those radiologists cut missed diagnoses by about 10% and reading time by more than 30% 12.

Zero labels, 15 million pairs

The asset vendors charge for is the hand-labeled dataset. RADAR skipped it. The model learned from 424,911 existing examinations, 1.5 million image-text pairs and more than 15 million anatomy-specific pairs, with no manual tagging, mined from a decade of reports at a single high-volume center and published in Science 348. Validation held off campus: across eight independent hospitals, AUC ran 0.874 to 0.912, against 0.913 internally 3.

Seventeen findings, cleared and billed

The same month, the regulated frontier moved. The FDA cleared a2z Radiology's Abdo-Triage to flag ten more findings on abdomen-pelvis CT, bringing its total to 17; the Boston startup, founded in 2024, has raised $5M 5. It sells what RADAR lacks: clearance, triage workflow, someone to hold liable 5.

The open model covers 146 findings; the FDA-cleared tool flags 17

050100150DAMO RADAR (open weights)146research-only license, no FDA clearanceAbdo-Triage (2026 clearance)17Abdo-Triage (2025 clearance)7
Data
Value
DAMO RADAR (open weights)146
Abdo-Triage (2026 clearance)17
Abdo-Triage (2025 clearance)7
Count of distinct clinical findings each system covers. RADAR: 146 diagnostic findings across 18 organs on contrast-enhanced CT per its Science evaluation, weights free under a non-commercial license. Abdo-Triage: suspected findings flagged for triage per its FDA clearances in 2025 and 2026. Sources: [1][3][5].1,3,5

The gap in that chart is the market's shape. One system covers 146 findings free for research; the other covers 17 findings and can be billed at the bedside.

Free weights, not a free product

Alibaba's own repository carries the catch. The project ships under CC BY-NC-SA 4.0, and the README states the model is "currently intended for research purposes only," with prospective clinical studies still required before clinical deployment 4. It reads contrast-enhanced abdominal CT and nothing else, and it holds no FDA clearance, so a US hospital running it diagnostically would be operating outside regulatory boundaries 46.

Annotated contrast-enhanced abdominal CT scan in axial and coronal views, with an arrow marking a lymph node between the aorta and the left renal vein.
A contrast-enhanced abdominal CT, the one scan type RADAR reads, annotated to flag a finding. The model covers 146 findings across 18 organs but ships without FDA clearance. · Hellerhoff, Wikimedia Commons (CC BY-SA 4.0)

Who deploys it first

Hospitals outside the FDA's reach can download the checkpoint today; US vendors keep their billing codes, for now 456. What the free model already repriced is labor: junior radiologists assisted by RADAR performed at or above the level of seniors working unaided 3. The weights were never the moat. The paperwork was.

How this brief was made

Become a contributor

Reporting on the business of AI and want it read? We take pitches from outside contributors who bring primary sources and a number worth arguing about.

Share

Deepdive

AI-generated from this story and its cited sources. Not investment advice.

Reader comments

0 comments

    Sign up

    Get your curated digest

    After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio